H1 Revenue Jump Raises Guidance, but Cash Conversion Looms as Key Test

What happened

Gorilla Technology reported H1 2026 revenue of US$78.4 million, up 99% year-over-year, and raised its FY2026 revenue outlook to at least US$200 million, surpassing the prior top-end guidance of $200 million. This comes after FY2025 results showed revenue of $101.4 million with negative operating cash flow and elevated accounts receivable plus unbilled receivables totaling $112.0 million, as emphasized in the deep value master report. The H1 revenue run-rate implies a substantial second-half acceleration to roughly $121.6 million, which will likely depend on timely delivery of GPU infrastructure and customer acceptance milestones. While top-line growth is encouraging, the company has yet to demonstrate that this revenue converts to cash; FY2025 gross profit actually declined despite revenue growth. Investors should remain critical of the quality of this revenue and await detailed interim financials, particularly balance sheet and cash flow statements, before revising the investment thesis.

Implication

The H1 announcement suggests management is executing on large contracts, but the key test remains working-capital management and operating cash flow. If accounts receivable and unbilled receivables have increased proportionally with revenue, the quality of earnings stays low and the company may need further financing. The raised guidance of at least $200 million implies a significant step-up in second-half deliveries, which could strain execution and acceptance; any slippage would disappoint. Current valuation around $12-13 per share still embeds substantial execution risk with limited margin of safety given the history of negative cash flow. A prudent approach is to wait for the next quarterly report showing a decline in receivables and positive operating cash flow before considering an entry near $10 or lower.

Thesis delta

The thesis that GRRR must prove cash conversion before becoming investable remains intact. The H1 revenue surge and raised guidance provide incremental evidence of contract execution but do not address the core risk of low-quality revenue. Therefore, the rating stays WAIT, with perhaps a slight increase in conviction that revenue targets are achievable, but the key trigger for an upgrade remains declining receivables and positive operating cash flow.